Fundz

Fundz Deep Dive

Everything you need to win Yukiteru Sugiyama — in one platform.

Who to reach, what to say, and why now on Yukiteru Sugiyama — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Yukiteru Sugiyama — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Ns Pharma, Inc. Appoints Yukiteru Sugiyama As President At Its Us Headquarters

PRIVATEJul 10, 2024•almost 2 years ago

Position

President

Company

NS Pharma

Yukiteru Sugiyama
ParamusBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Yukiteru Sugiyama, Ph.D., has been appointed as the new President of NS Pharma, Inc. at its US headquarters, replacing retiring president Tsugio Tanaka, MSc as of June 30, 2024. Sugiyama brings with him extensive experience in research, clinical development, and commercial functions, with a focus on empathy for patients and transparency between stakeholders.

Company Information

Company

NS Pharma

Location

Paramus, New Jersey, United States

About

NS Pharma, Inc., is a wholly owned subsidiary of Nippon Shinyaku Co., Ltd. NS Pharma is a registered trademark of the Nippon Shinyaku group of companies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for NS Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.